Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
47 巻, 9 号
選択された号の論文の14件中1~14を表示しています
ORIGINAL ARTICLES
  • Hiroshi Yamaguchi, Kazuo Komamura, Masahito Choraku, Akira Hirono, Nob ...
    2008 年 47 巻 9 号 p. 819-825
    発行日: 2008年
    公開日: 2008/05/01
    ジャーナル オープンアクセス
    Objective Previous research revealed that a low concentration of serum insulin-like growth factor-1 (IGF-1) is associated with risks of myocardial infarction and heart failure. We hypothesized that the serum IGF-1 level affects clinical outcome in acute myocardial infarction (AMI). We examined the impact of serum IGF-1 in acute phase of AMI on 90-day mortality.
    Patients and Methods In 54 patients with AMI, we measured serum total IGF-1 concentration on admission, in acute phase (1.9±0.5 days) and in chronic phase (28.5±6.7 days). We measured plasma brain natriuretic peptide (BNP), glucose and insulin in acute phase, and calculated insulin resistance (HOMA-R).
    Results Serum IGF-1 was 135.6±51.1 ng/ml on admission and significantly decreased to 105.5±42.2 ng/ml in acute phase, and then returned to baseline of 136.7±52.2 ng/ml in chronic phase. Five patients died of cardiac reasons within 90 days, all of whom had lower IGF-1 on admission and lower IGF-1 in acute phase than their median of 54 patients. Patients with the concentration of IGF-1 on admission below the median (<131 ng/ml) had significantly lower survival rate than those at or above the median (log-rank test p=0.0169). However, patients with BNP concentration at or above the median (≥227 pg/ml) had a similar survival rate to those below the median (log-rank test p=0.6797). Multivariate analysis clarified that IGF-1 on admission was the sole independent predictor of 90-day mortality (p=0.007, risk ratio=0.927).
    Conclusion A low concentration of serum IGF-1 on admission was associated with a poor early prognosis of acute myocardial infarction.
  • Zoran Gluvic, Miodrag Slovic, Predrag Dugalic, Ratko Tomasevic, Aleksa ...
    2008 年 47 巻 9 号 p. 827-831
    発行日: 2008年
    公開日: 2008/05/01
    ジャーナル オープンアクセス
    Objective This study examined the sensitivity of routine abdominal ultrasound scanning in the detection of colonic malignancy.
    Patients and Methods A case control prospective study included 101 patients hospitalized at the Department of Gastroenterology and Liver Diseases of Zemun Clinical Hospital over a four-year period. Since the complaints pointed to colonic malignancy, the patients underwent routine golden standard diagnostic procedures. These patients were referred to an experienced abdominal ultrasound operator who searched for some characteristic signs of colonic malignancy. All of the participants were surgically treated after the completion of relevant procedures for diagnosing colonic malignancy. SPSS for Windows 10.0 was used for data analysis.
    Results The sensitivity of an abdominal ultrasound scan in the detection and location of pathological changes pointed to colonic malignancy was different- 76% and 84% respectively. This method was very reliable in detecting right-sided colonic carcinoma (100%). Some specific ultrasonographic signs of colonic carcinoma were observed at the advanced stages of disease.
    Conclusions The routine abdominal ultrasonography can be used for the screening of colonic malignancy owing to its high sensitivity, particularly in advanced disease, but solely in conjunction with other methods. Finally, abdominal ultrasonography cannot be a definitive diagnostic tool for colonic carcinoma.
  • Ekrem Cengiz Seyhan, Erdogan Cetinkaya, Sedat Altin, Zeki Gunluoglu, A ...
    2008 年 47 巻 9 号 p. 833-838
    発行日: 2008年
    公開日: 2008/05/01
    ジャーナル オープンアクセス
    Background As reported recently, some gene polymorphisms are suspected to determine susceptibility to sarcoidosis and are held responsible for the extent and progression of the disease. Polymorphism at -857 locus of tumor necrosis factor (TNF)-α gene is considered to be a predisposition factor in sarcoidosis and held responsible for pathogenesis of the disease. We compared these polymorphisms in healthy Turkish control subjects and Turkish patients with sarcoidosis.
    Methods We examined gene polymorphisms in 90 cases which were histopathologically diagnosed as sarcoidosis and 110 healthy subjects without any history of a chronic disease. TNF-α-857 gene polymorphisms were determined using a polymerase chain reaction (PCR)-based method after DNA isolation. Genotype distributions of the groups were evaluated by the Hardy-Weinberg equilibrium test.
    Results Genotype distributions were in agreement with the Hardy-Weinberg equilibrium both in sarcoidosis patients and healthy subjects. TNF-α gene (C/T) polymorphism, at position -857, revealed no differences in genotype and allele frequency between patients and control subjects but more relapses and more frequently involvement of three or more organs were found in sarcoidosis patients who have this polymorphism (p<0.05, p<0.01 respectively).
    Conclusion T allele at -857 locus of TNF gene is a marker for more extensive disease in Turkish sarcoidosis patients.
  • Satoru Joshita, Kiyoshi Kitano, Tadanobu Nagaya, Atsushi Kamijo, Koh N ...
    2008 年 47 巻 9 号 p. 839-842
    発行日: 2008年
    公開日: 2008/05/01
    ジャーナル オープンアクセス
    Here we report two patients with hematological malignancies associated with complications of fatal cardiac zygomycosis. The first case, a 72-year-old man with myelodysplastic syndrome being treated with low-dose cytarabine, died of sudden cardiac arrest. An autopsy revealed disseminated zygomycosis accompanied with occlusion of the coronary artery by fungal thrombi. The second case, a 52-year-old woman with acute lymphoblastic leukemia, developed febrile neutropenia and skin eruptions with induration on the face and extremities during the first induction chemotherapy. She experienced sudden bradycardia with unstable hemodynamics and died of acute myocardial infarction. Histological examination of a skin biopsy demonstrated zygomycosis. In light of the above, it should be kept in mind that cardiac zygomycosis might occur in hematologically compromised patients presenting with acute myocardial infarction.
CASE REPORTS
PICTURES IN CLINICAL MEDICINES
feedback
Top